Variant report

Variant	esv3361627
Chromosome Location	chr8:39806082-39807339
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr8:39806853-39807579	H1-hESC	embryonic stem cell:	n/a	n/a
2	BRCA1	chr8:39805918-39806105	H1-hESC	embryonic stem cell:	n/a	chr8:39805983-39805990
3	CEBPB	chr8:39807038-39807477	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD1	chr8:39806830-39807075	H1-hESC	embryonic stem cell:	n/a	n/a
5	CHD1	chr8:39806290-39806471	H1-hESC	embryonic stem cell:	n/a	n/a
6	CHD2	chr8:39806927-39807416	H1-hESC	embryonic stem cell:	n/a	n/a
7	CHD2	chr8:39805814-39806122	H1-hESC	embryonic stem cell:	n/a	n/a
8	CUX1	chr8:39806689-39807092	GM12878	blood:	n/a	chr8:39806924-39806938
9	EBF1	chr8:39806874-39807049	GM12878	blood:	n/a	n/a
10	EP300	chr8:39806714-39807064	GM12878	blood:	n/a	chr8:39806996-39807010 chr8:39806944-39806958
11	EP300	chr8:39807059-39807458	H1-hESC	embryonic stem cell:	n/a	n/a
12	EP300	chr8:39806860-39807131	GM12878	blood:	n/a	chr8:39806996-39807010 chr8:39806944-39806958
13	HDAC2	chr8:39807073-39807394	H1-hESC	embryonic stem cell:	n/a	chr8:39807325-39807339
14	JUND	chr8:39806934-39807122	H1-hESC	embryonic stem cell:	n/a	n/a
15	MAFK	chr8:39807025-39807225	H1-hESC	embryonic stem cell:	n/a	n/a
16	POLR2A	chr8:39805864-39806305	H1-hESC	embryonic stem cell:	n/a	n/a
17	POLR2A	chr8:39807055-39807345	H1-hESC	embryonic stem cell:	n/a	n/a
18	POLR2A	chr8:39806140-39806299	H1-hESC	embryonic stem cell:	n/a	n/a
19	POLR2A	chr8:39807325-39808311	H1-hESC	embryonic stem cell:	n/a	n/a
20	POU5F1	chr8:39806990-39807524	H1-hESC	embryonic stem cell:	n/a	chr8:39807465-39807479 chr8:39807286-39807300 chr8:39807224-39807238 chr8:39807286-39807300 chr8:39807464-39807478 chr8:39807224-39807238 chr8:39807224-39807238 chr8:39807309-39807323 chr8:39807464-39807478 chr8:39807225-39807239 chr8:39807464-39807478 chr8:39807286-39807300
21	RUNX3	chr8:39806196-39806389	GM12878	blood:	n/a	chr8:39806335-39806344 chr8:39806335-39806344
22	RUNX3	chr8:39806120-39806514	GM12878	blood:	n/a	chr8:39806335-39806344 chr8:39806335-39806344
23	RUNX3	chr8:39806845-39807096	GM12878	blood:	n/a	n/a
24	SPI1	chr8:39805973-39806666	GM12878	blood:	n/a	n/a
25	SPI1	chr8:39806771-39807082	GM12891	blood:	n/a	n/a
26	SPI1	chr8:39806193-39806517	GM12878	blood:	n/a	n/a
27	SPI1	chr8:39806146-39806477	GM12891	blood:	n/a	n/a
28	STAT3	chr8:39806402-39806473	MCF10A-Er-Src	breast:	n/a	n/a
29	TBP	chr8:39805971-39806225	H1-hESC	embryonic stem cell:	n/a	n/a
30	TBP	chr8:39806745-39807059	GM12878	blood:	n/a	n/a
31	TBP	chr8:39807157-39807355	H1-hESC	embryonic stem cell:	n/a	n/a
32	TEAD4	chr8:39806949-39807356	H1-hESC	embryonic stem cell:	n/a	n/a
33	WRNIP1	chr8:39806222-39806778	GM12878	blood:	n/a	n/a
34	ZNF384	chr8:39806854-39806980	GM12878	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:39806701-39806751	NH-A	brain:	n/a
2	chr8:39806701-39806751	HRCEpiC	kidney:	n/a
3	chr8:39806701-39806751	HCM	heart:	n/a
4	chr8:39806701-39806751	MCF10A-Er-Src	breast:	n/a
5	chr8:39806701-39806751	AG09309	skin:	n/a
6	chr8:39806701-39806751	HIPEpiC	eye:	n/a
7	chr8:39806701-39806751	Hepatocyte	liver:	n/a
8	chr8:39806701-39806751	HL-60	blood:	n/a
9	chr8:39806701-39806751	SAEC	small airway:	n/a
10	chr8:39806701-39806751	Jurkat	blood:	n/a
11	chr8:39806701-39806751	AoSMC	blood vessel:	n/a
12	chr8:39806701-39806751	GM12891	blood:	n/a
13	chr8:39806701-39806751	AG09319	gingival:	n/a
14	chr8:39806701-39806751	T-47D	breast:	n/a
15	chr8:39806701-39806751	AG10803	skin:	n/a
16	chr8:39806701-39806751	NT2-D1	testis:	n/a
17	chr8:39806701-39806751	GM12892	blood:	n/a
18	chr8:39806701-39806751	HEK293	kidney:	embryo
19	chr8:39806701-39806751	LNCaP	prostate:	n/a
20	chr8:39806701-39806751	NHDF-neo	bronchial:	n/a
21	chr8:39806701-39806751	U87	brain:	n/a
22	chr8:39806701-39806751	HCF	heart:	n/a
23	chr8:39806701-39806751	A549	lung:	n/a
24	chr8:39806701-39806751	AG04450	lung:	fetal
25	chr8:39806701-39806751	ovcar-3	ovarian:	n/a
26	chr8:39806701-39806751	IMR90	lung:	fetal
27	chr8:39806701-39806751	HRE	kidney:	n/a
28	chr8:39806701-39806751	HMEC	breast:	n/a
29	chr8:39806701-39806751	HCT-116	colon:	n/a
30	chr8:39806701-39806751	HepG2	liver:	n/a
31	chr8:39806701-39806751	BE2_C	brain:	n/a
32	chr8:39806701-39806751	SK-N-SH	brain:	n/a
33	chr8:39806701-39806751	K562	blood:	n/a
34	chr8:39806701-39806751	BJ	skin:	n/a
35	chr8:39806701-39806751	H1-hESC	embryonic stem cell:	embryo
36	chr8:39806701-39806751	HRPEpiC	eye:	n/a
37	chr8:39806701-39806751	HEEpiC	esophagus:	n/a
38	chr8:39806701-39806751	GM19239	blood:	n/a
39	chr8:39806701-39806751	AG04449	skin:	fetal
40	chr8:39806701-39806751	ECC-1	luminal epithelium:	n/a
41	chr8:39806701-39806751	GM06990	blood:	n/a
42	chr8:39806701-39806751	CMK	blood:	n/a
43	chr8:39806701-39806751	HPAEpiC	pulmonary alveolar:	n/a
44	chr8:39806701-39806751	ProgFib	skin:	n/a
45	chr8:39806701-39806751	HNPCEpiC	eye:	n/a
46	chr8:39806701-39806751	SK-N-SH_RA	brain:	n/a
47	chr8:39806701-39806751	Hela-S3	cervix:	n/a
48	chr8:39806701-39806751	MCF-7	breast:	n/a
49	chr8:39806701-39806751	Caco-2	colon:	n/a
50	chr8:39806701-39806751	PrEC	prostate:	n/a

Variant related genes	Relation type
IDO2	TF binding region
IDO2	CpG island

Extended variants
information (count: 45 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:45 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs576187755	chr8:39806117-39806118	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs150668816	chr8:39806194-39806195	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs561886625	chr8:39806205-39806206	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs184102028	chr8:39806241-39806242	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs10085935	chr8:39806267-39806268	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs541072356	chr8:39806299-39806300	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs188541737	chr8:39806350-39806351	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs558968974	chr8:39806384-39806385	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs370082772	chr8:39806440-39806441	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs10103702	chr8:39806492-39806493	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs532754634	chr8:39806518-39806519	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs532613293	chr8:39806532-39806533	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs138886694	chr8:39806546-39806547	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs142277876	chr8:39806569-39806570	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs527430257	chr8:39806578-39806579	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs552483045	chr8:39806585-39806586	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs146389838	chr8:39806597-39806598	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs181350309	chr8:39806600-39806601	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs529980785	chr8:39806604-39806605	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs549831709	chr8:39806605-39806606	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs373351846	chr8:39806613-39806614	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs186816395	chr8:39806617-39806618	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs538447506	chr8:39806656-39806657	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs371207927	chr8:39806711-39806712	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs558375592	chr8:39806718-39806719	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs374783965	chr8:39806757-39806758	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs369022230	chr8:39806760-39806761	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs78506470	chr8:39806834-39806835	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs190150538	chr8:39806881-39806882	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs182391550	chr8:39806910-39806911	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs61020637	chr8:39806945-39806946	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs544058307	chr8:39806948-39806949	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs186385368	chr8:39806978-39806979	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs577468685	chr8:39806983-39806984	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs546417212	chr8:39807027-39807028	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs139741766	chr8:39807065-39807066	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs12677574	chr8:39807097-39807098	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs10104314	chr8:39807161-39807162	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs560912573	chr8:39807244-39807245	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs568601093	chr8:39807251-39807252	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs4737171	chr8:39807281-39807282	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs569845787	chr8:39807286-39807287	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs189662403	chr8:39807293-39807294	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs554237780	chr8:39807315-39807316	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs372946704	chr8:39807317-39807318	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Prostate cancer	21965145	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Colorectal cancer	16272173	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
Myxofibrosarcoma	16751306	CNVD
Immune disease	21572526	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Kallmann Syndrome 2	22470819	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Pancreatic cancer	21811587	CNVD
Multiple myeloma	16461302	CNVD
Developmental delay	21373258	CNVD
Thyroid cancer	19087340	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	17603634	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Disorders of sex development	21048976	CNVD
Testicular cancer	18059402	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hepatocellular carcinoma	16750200	CNVD
Bladder cancer	19088036	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Breast cancer	17001308	CNVD
Breast cancer	17157792	CNVD
Cancer	17001308	CNVD
Cancer	18840272	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Chordoma	18071362	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Breast cancer	16608533	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21785460	CNVD
abnormal development	18461090	CNVD
Rhabdomyosarcoma	16790082	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Cancer	20164920	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Medulloblastoma	19270706	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:47 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:39796600-39806200	Weak transcription	Small Intestine	intestine
2	chr8:39797800-39808400	Weak transcription	Fetal Lung	lung
3	chr8:39797800-39808800	Weak transcription	Left Ventricle	heart
4	chr8:39802800-39808800	Weak transcription	Lung	lung
5	chr8:39803400-39809200	Enhancers	Primary monocytes fromperipheralblood	blood
6	chr8:39804400-39806200	Weak transcription	K562	blood
7	chr8:39804400-39809200	Enhancers	Primary B cells from peripheral blood	blood
8	chr8:39805000-39807200	Enhancers	ES-I3 Cell Line	embryonic stem cell
9	chr8:39805000-39809800	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr8:39805400-39806400	Enhancers	Primary B cells from cord blood	blood
11	chr8:39805400-39806800	Enhancers	H9 Cell Line	embryonic stem cell
12	chr8:39805400-39810200	Enhancers	Primary hematopoietic stem cells	blood
13	chr8:39805600-39806200	Enhancers	A549	lung
14	chr8:39805600-39807200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr8:39805600-39807600	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr8:39805600-39807600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
17	chr8:39805600-39807800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr8:39805600-39808000	Enhancers	iPS-15b Cell Line	embryonic stem cell
19	chr8:39805600-39808200	Enhancers	HUES6 Cell Line	embryonic stem cell
20	chr8:39805600-39808600	Enhancers	iPS-18 Cell Line	embryonic stem cell
21	chr8:39805600-39809200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
22	chr8:39805800-39806200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
23	chr8:39805800-39807200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
24	chr8:39805800-39808000	Enhancers	H1 Cell Line	embryonic stem cell
25	chr8:39806000-39806200	Enhancers	HUES48 Cell Line	embryonic stem cell
26	chr8:39806000-39807600	Flanking Active TSS	GM12878-XiMat	blood
27	chr8:39806000-39817000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
28	chr8:39806200-39806400	Enhancers	K562	blood
29	chr8:39806200-39806600	Enhancers	Primary neutrophils fromperipheralblood	blood
30	chr8:39806200-39806800	Enhancers	Small Intestine	intestine
31	chr8:39806200-39806800	Enhancers	HepG2	liver
32	chr8:39806200-39807000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
33	chr8:39806200-39807000	Flanking Active TSS	A549	lung
34	chr8:39806200-39810000	Active TSS	Liver	Liver
35	chr8:39806400-39806600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
36	chr8:39806400-39807000	Weak transcription	K562	blood
37	chr8:39806400-39807600	Flanking Active TSS	Primary B cells from cord blood	blood
38	chr8:39806600-39807200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
39	chr8:39806600-39807600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
40	chr8:39806800-39808000	Weak transcription	H9 Cell Line	embryonic stem cell
41	chr8:39807000-39807600	Enhancers	K562	blood
42	chr8:39807000-39808200	Enhancers	HUES48 Cell Line	embryonic stem cell
43	chr8:39807000-39809400	Weak transcription	A549	lung
44	chr8:39807200-39807600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
45	chr8:39807200-39807600	Enhancers	iPS-20b Cell Line	embryonic stem cell
46	chr8:39807200-39807600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr8:39807200-39809000	Enhancers	Primary neutrophils fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links